Cargando…

Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern

The SARS-CoV-2 Omicron variant harbors more than 30 mutations in its spike (S) protein. Circulating Omicron subvariants, particularly BA5 and other variants of concern (VOCs), show increased resistance to COVID-19 vaccines that target the original S protein, calling for an urgent need for effective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Juan, Wang, Gang, Zheng, Jian, Verma, Abhishek K., Guan, Xiaoqing, Malisheni, Moffat M., Geng, Qibin, Li, Fang, Perlman, Stanley, Du, Lanying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762654/ https://www.ncbi.nlm.nih.gov/pubmed/36535987 http://dx.doi.org/10.1038/s41541-022-00580-z

Ejemplares similares

A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection
por: Shi, Juan, et al.
Publicado: (2022)

mRNA vaccines elicit potent neutralization against multiple SARS-CoV-2 omicron subvariants and other variants of concern
por: Wang, Gang, et al.
Publicado: (2022)

Neutralizing antibodies and their cocktails against SARS-CoV-2 Omicron and other circulating variants
por: Yang, Yang, et al.
Publicado: (2022)

Glycosylated Delta-receptor-binding domain mucosal vaccine elicits broadly neutralizing antibodies with protection against SARS-CoV-2 challenge
por: Guan, Xiaoqing, et al.
Publicado: (2023)

RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge
por: Shi, Juan, et al.
Publicado: (2022)

Vaccine booster efficiently inhibits entry of SARS-CoV-2 omicron variant
por: Zhang, Wei, et al.
Publicado: (2022)

The Omicron variant of concern: Diversification and convergent evolution in spike protein, and escape from anti-Spike monoclonal antibodies
por: Focosi, Daniele, et al.
Publicado: (2022)

Omicron: a mysterious variant of concern
por: Gowrisankar, A., et al.
Publicado: (2022)

Genomic and structural mechanistic insight to reveal the differential infectivity of omicron and other variants of concern
por: Sharma, Priyanka, et al.
Publicado: (2022)

A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern
por: Yuan, Mengqi, et al.
Publicado: (2022)

Structural basis for mouse receptor recognition by SARS-CoV-2 omicron variant
por: Zhang, Wei, et al.
Publicado: (2022)

World Facing the latest variant of Concern---------Omicron
por: Javaid, Muhammad Mohsin, et al.
Publicado: (2022)

Molecular switches regulating the potency and immune evasiveness of SARS-CoV-2 spike protein
por: Wan, Yushun, et al.
Publicado: (2021)

Emergence of Genomic Diversity in the Spike Protein of the “Omicron” Variant
por: Basak, Surajit, et al.
Publicado: (2023)

Curcumin inhibits spike protein of new SARS-CoV-2 variant of concern (VOC) Omicron, an in silico study
por: Nag, Anish, et al.
Publicado: (2022)

Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1
por: Geng, Qibin, et al.
Publicado: (2022)

MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection
por: Tai, Wanbo, et al.
Publicado: (2023)

Omicron: A variant of concern not a cause of panic
por: Arora, Shefali
Publicado: (2022)

Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemic
por: Cohen, Dani, et al.
Publicado: (2023)

SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron
por: Mazzoni, Alessio, et al.
Publicado: (2022)

Interactions between heparin and SARS-CoV-2 spike glycoprotein RBD from omicron and other variants
por: Gelbach, Adrianne L., et al.
Publicado: (2022)

Omicron Spike Protein is Vulnerable to Reduction
por: Yao, Zhong, et al.
Publicado: (2023)

Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern
por: Vangeel, Laura, et al.
Publicado: (2022)

Potent Neutralization of Omicron and other SARS-CoV-2 Variants of Concern by Biparatopic Human VH Domains
por: Chen, Chuan, et al.
Publicado: (2022)

Performance of SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Tests for Omicron and Other Variants of Concern
por: Raïch-Regué, Dàlia, et al.
Publicado: (2022)

Anti-SARS-CoV-2 immunoadhesin remains effective against Omicron and other emerging variants of concern
por: Cohen-Dvashi, Hadas, et al.
Publicado: (2022)

Characteristic analysis of Omicron‐included SARS‐CoV‐2 variants of concern
por: Yang, Hao, et al.
Publicado: (2022)

Is Omicron the last SARS-CoV-2 Variant of Concern?
por: Rahimi, Farid, et al.
Publicado: (2022)

The Omicron variant of concern: The genomics, diagnostics, and clinical characteristics in children
por: Setiabudi, Djatnika, et al.
Publicado: (2022)

IMM-BCP-01, a patient-derived anti-SARS-CoV-2 antibody cocktail, is active across variants of concern including Omicron BA.1 and BA.2
por: Nikitin, Pavel A., et al.
Publicado: (2022)

A spike protein S2 antibody efficiently neutralizes the Omicron variant
por: Hu, Jia, et al.
Publicado: (2022)

Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?
por: Jung, Christoph, et al.
Publicado: (2022)

The effectiveness of tenofovir-based pre-exposure prophylaxis for prevention of HIV acquisition among sub-Saharan African women at high risk: a systematic review
por: Murewanhema, Grant, et al.
Publicado: (2021)

Decreased severity of the Omicron variant of concern: further evidence from Italy
por: Divino, Fabio, et al.
Publicado: (2022)

Omicron: A SARS‐CoV‐2 variant of real concern
por: Gattinger, Pia, et al.
Publicado: (2022)

Third booster vaccination and stopping the Omicron, a new variant of concern
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Third booster vaccination and stopping the Omicron, a new variant of concern
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants of concern
por: Du, Wenjuan, et al.
Publicado: (2022)

Spiking immunotherapy with a bacterial cocktail brings T cells back to the fight
por: Greathouse, K. Leigh, et al.
Publicado: (2021)

The Spike of Concern—The Novel Variants of SARS-CoV-2
por: Winger, Anna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ioo7qfba3qdub6gq7jrks0tvp1